Skip to main content
Top
Published in: Rheumatology International 4/2003

01-07-2003 | Case Report

Catastrophic antiphospholipid syndrome masquerading as ischaemic colitis

Authors: Jan Steffen Jürgensen, Ralf Kettritz, Wolfgang Schneider, Herbert Koop, Thorsten Sven Hildebrand, Ulrich Frei, Kai-Uwe Eckardt

Published in: Rheumatology International | Issue 4/2003

Login to get access

Abstract

We describe a young woman whose initial presentation was dominated by acute diarrhoea. Life-threatening multiorgan failure rapidly ensued and necessitated mechanical ventilation and dialysis treatment. An initially elongated activated partial thromboplastin time prompted further coagulation tests that led to the detection of positive lupus anticoagulant, a highly elevated IgG-anticardiolipin (aCL) antibody titre, and prolonged dilute Russell's viper venom time. Histological examination of samples obtained during endoscopy revealed widespread intestinal thrombotic microangiopathy. In view of these serologic and histologic features, a diagnosis of the malignant variant of the antiphospholipid syndrome (APS), also termed 'catastrophic APS', was established. In spite of this syndrome's grim prognosis, the patient recovered following intensive anticoagulation and adjunct treatment with steroids and immunoglobulins.
Literature
1.
go back to reference Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311PubMed Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311PubMed
2.
go back to reference Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346:752–763PubMed Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346:752–763PubMed
3.
go back to reference Greaves M (1999) Thrombosis series: antiphospholipid antibodies and thrombosis. Lancet 353:1348–1353PubMed Greaves M (1999) Thrombosis series: antiphospholipid antibodies and thrombosis. Lancet 353:1348–1353PubMed
4.
go back to reference Triplett DA, Asherson RA (2000) Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS). Am J Hematol 65:154–159CrossRefPubMed Triplett DA, Asherson RA (2000) Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS). Am J Hematol 65:154–159CrossRefPubMed
5.
go back to reference Asherson RA (1992) The catastrophic antiphospholipid syndrome. J Rheumatol 19:508–512PubMed Asherson RA (1992) The catastrophic antiphospholipid syndrome. J Rheumatol 19:508–512PubMed
6.
go back to reference Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332:993–997CrossRefPubMed Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332:993–997CrossRefPubMed
7.
go back to reference Asherson RA, Cervera R, Piette JC, Shoenfeld Y, Espinosa G, Petri MA, Lim E, Lau TC, Gurjal A, Jedryka-Goral A, Chwalinska-Sadowska H, Dibner RJ, Rojas-Rodriguez J, Garcia-Carrasco M, Grandone JT, Parke AL, Barbosa P, Vasconcelos C, Ramos-Casals M, Font J, Ingelmo M (2001) Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80:355–377 Asherson RA, Cervera R, Piette JC, Shoenfeld Y, Espinosa G, Petri MA, Lim E, Lau TC, Gurjal A, Jedryka-Goral A, Chwalinska-Sadowska H, Dibner RJ, Rojas-Rodriguez J, Garcia-Carrasco M, Grandone JT, Parke AL, Barbosa P, Vasconcelos C, Ramos-Casals M, Font J, Ingelmo M (2001) Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80:355–377
8.
go back to reference Brunner HI, Chan W-S, Ginsberg JS, Feldman BM (2002) Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. Results of a decision analysis. J Rheumatol 29:490–501PubMed Brunner HI, Chan W-S, Ginsberg JS, Feldman BM (2002) Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. Results of a decision analysis. J Rheumatol 29:490–501PubMed
9.
go back to reference Asherson RA (1998) The catastrophic antiphospholipid syndrome. A review of the clinical features, possible pathogenesis and treatment. Lupus 7 [Suppl 2]:S55–S62 Asherson RA (1998) The catastrophic antiphospholipid syndrome. A review of the clinical features, possible pathogenesis and treatment. Lupus 7 [Suppl 2]:S55–S62
10.
go back to reference Cappell MS, Mikhail N, Gujral N (1994) Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies. Dig Dis Sci 39:1359–1364PubMed Cappell MS, Mikhail N, Gujral N (1994) Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies. Dig Dis Sci 39:1359–1364PubMed
11.
go back to reference Kaushik S, Federle M, Schur PH, Krishnan M, Silverman SG, Ros PR (2001) Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. Radiology 218:768–771PubMed Kaushik S, Federle M, Schur PH, Krishnan M, Silverman SG, Ros PR (2001) Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. Radiology 218:768–771PubMed
12.
go back to reference Rojas-Rodriguez J, Garcia-Carrasco M, Ramos-Casals M, Enriquez-Coronel G, Colchero C, Cervera R, Font J (2000) Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients. J Rheumatol 27:238–240PubMed Rojas-Rodriguez J, Garcia-Carrasco M, Ramos-Casals M, Enriquez-Coronel G, Colchero C, Cervera R, Font J (2000) Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients. J Rheumatol 27:238–240PubMed
13.
go back to reference Asherson RA, Schoenfeld Y (2000) The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome—molecular mimicry? J Rheumatol 27:12–14PubMed Asherson RA, Schoenfeld Y (2000) The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome—molecular mimicry? J Rheumatol 27:12–14PubMed
14.
go back to reference Olguin-Ortega L, Barile-Fabris L (2001) Catastrophic antiphospholipid syndrome: need for a reappraisal [letter]. Asherson RA [reply] J Rheumatol 28:1934–1935PubMed Olguin-Ortega L, Barile-Fabris L (2001) Catastrophic antiphospholipid syndrome: need for a reappraisal [letter]. Asherson RA [reply] J Rheumatol 28:1934–1935PubMed
Metadata
Title
Catastrophic antiphospholipid syndrome masquerading as ischaemic colitis
Authors
Jan Steffen Jürgensen
Ralf Kettritz
Wolfgang Schneider
Herbert Koop
Thorsten Sven Hildebrand
Ulrich Frei
Kai-Uwe Eckardt
Publication date
01-07-2003
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2003
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-003-0296-1

Other articles of this Issue 4/2003

Rheumatology International 4/2003 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.